UPDATE 4-EpiPen maker Mylan to restructure, cut workforce

Dec 7 (Reuters) - Generic drugmaker Mylan NV, which
has been under fire for price hikes on the life-saving EpiPen
allergy treatment, said on Wednesday that it expected to cut
less than 10 percent of...